Crescent Biopharma (CBIO)
Crescent Biopharma (CBIO) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- CBIO last traded at $13.00 on 2026-11-20, 0.70% for the session.
- Crescent Biopharma: market cap $505.64M, revenue $15.00M over the last four quarters.
- Over the past year CBIO returned -0.23%, with a year-to-date return of 9.61%.